|
시장보고서
상품코드
2084766
모르핀, 부프레노르핀, 기타 의약품 시장 : 의약품별, 용도별, 투여 경로별, 유통 채널별, 지역별Morphine, Buprenorphine, and Other Drugs Market, By Drug, By Application, By Route Of Administration, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
모르핀, 부프레노르핀, 기타 의약품 시장은 2026년에 99억 4,000만 달러 규모가 될 것으로 추정되며, 2033년까지 139억 7,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 6.2%로 성장할 것으로 전망됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 99억 4,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 6.20% | 예측 금액(2033년) | 139억 7,000만 달러 |
모르핀, 부프레노르핀 및 기타 유사 약물은 오피오이드 약물로 알려져 있습니다. 아편은 양귀비 열매에서 얻어지는 짙은 갈색의 수지상 물질로, 알칼로이드를 함유하고 있습니다. 오피오이드에는 모르핀, 부프레노르핀, 노스카핀, 테바인, 에트르핀 및 기타 유사 물질이 포함됩니다. 모르핀은 아편의 주요 알칼로이드이며, 이 계열 약물의 원형으로 여겨집니다. 오피오이드는 진정 작용과 진통 작용이 있으며, 일반적으로 통증 관리에 사용됩니다. 오피오이드는 외상성 통증, 내장성 통증, 허혈성 통증, 수술 후 통증, 화상 통증 및 암성 통증에 일반적으로 사용됩니다. 시장의 성장은 주로 전 세계 암 유병률의 증가에 기인한 것으로 보입니다.
시장 역학
세계 모르핀, 부프레노르핀, 기타 의약품 시장의 성장에 기여하는 주요 요인은 암, 만성 통증(수술 후 통증, 요통), 관절염, 섬유근육통 등의 질환 유병률 증가입니다. 암 환자의 중등도에서 중증 통증 관리에는 몇 가지 아편계 진통제가 권장됩니다. 예를 들어, 미국 질병통제예방센터(CDC)에 따르면, 암은 미국에서 주요 사망 원인 중 하나입니다. 또한, 2021년 ‘미국 암 통계’에 따르면, 2018년에는 170만 8,923명의 미국인이 암 진단을 받았습니다. 따라서, 높은 암 유병률과 암 치료에서의 오피오이드 사용이 시장 성장을 견인할 것으로 예상됩니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장의 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 인사이트도 제공하고 있습니다.
- 전 세계 모르핀, 부프레노르핀 및 기타 의약품 시장의 주요 기업 개요을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)에 근거하여 게재하고 있습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 모르핀, 부프레노르핀, 기타 의약품 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 모르핀, 부프레노르핀 및 기타 의약품 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 모르핀, 부프레노르핀, 기타 의약품 시장 : 의약품별(2021-2033년)
제5장 모르핀, 부프레노르핀, 기타 의약품 시장 : 용도별(2021-2033년)
제6장 모르핀, 부프레노르핀, 기타 의약품 시장 : 투여 경로별(2021-2033년)
제7장 모르핀, 부프레노르핀, 기타 의약품 시장 : 유통 채널별(2021-2033년)
제8장 모르핀, 부프레노르핀, 기타 의약품 시장 : 지역별(2021-2033년)
제9장 경쟁 구도
제10장 섹션
KSM 26.07.16Morphine, Buprenorphine, and Other Drugs Market is estimated to be valued at USD 9.94 Bn in 2026 and is expected to reach USD 13.97 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 9.94 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.20% | 2033 Value Projection: | USD 13.97 Bn |
Morphine, buprenorphine, and other similar drugs are known as opioid drugs. Opium is dark brown, resinous material obtained from poppy capsule called opium containing alkaloids. Opioids include morphine, buprenorphine, noscapine, thebaine, etrophine, and other similar substances. Morphine is principle alkaloid in opium and is described prototype of this class of drugs. Opioids have sedative and analgesic effects, and are commonly used for pain management. Opioids are commonly indicated in traumatic, visceral, ischaemic, postoperative burn, and cancer pain. The growth in the market can be primarily attributed to the growing prevalence of cancer worldwide.
Market Dynamics
The key drivers contributing to the global morphine, buprenorphine and other drug market's growth is the increase in prevalence of diseases such as cancer, chronic pain (post-surgical pain, lower back pain), arthritis, and fibromyalgia. Several narcotic drugs are recommended for the management of moderate to severe pain in cancer patients. For instance, according to Centers for Disease Control and Prevention (CDC) cancer is one of leading causes of deaths in the U.S. Furthermore, according to U.S. Cancer Statistics of 2021 in 2018 1,708,923 Americans were diagnosed with cancer. Thus, owing to prevalence of cancer and use of opioids for treatment of cancer is expected to drive the market growth.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the morphine, buprenorphine and other drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Purdue Pharma, Sun Pharmaceuticals, Pfizer Inc. , West Ward Pharmaceuticals, Teva Pharmaceuticals, Piramal Pharmaceuticals, Hikama Pharmaceuticals, Indivior PLC, Oreoxo AB, Camurus AB, and Novartis
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The morphine, buprenorphine, and other drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global morphine, buprenorphine, and other drugs market
Market Segmentation
- By Drug (Revenue, USD Bn, 2021-2033)
- Morphine
- Buprenorphine
- Noscapin
- Thebaine
- Etrophine
- By Application (Revenue, USD Bn, 2021-2033)
- Pain Management
- Opioid Addiction Treatment
- Others
- By Route Of Administration (Revenue, USD Bn, 2021-2033)
- Injectable
- Oral
- Transdermal
- By Distribution Channel (Revenue, USD Bn, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Others
- By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Purdue Pharma
- Sun Pharmaceuticals
- Pfizer Inc.
- West Ward Pharmaceuticals
- Teva Pharmaceuticals
- Piramal Pharmaceuticals
- Hikama Pharmaceuticals
- Indivior PLC
- Oreoxo AB
- Camurus AB
- Novartis
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug
- Market Snapshot, By Application
- Market Snapshot, By Route Of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter's Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
4. Morphine, Buprenorphine, and Other Drugs Market, By Drug, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Morphine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Buprenorphine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Noscapine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Thebaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Etrophine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
5. Morphine, Buprenorphine, and Other Drugs Market, By Application, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Opioid Addiction Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
6. Morphine, Buprenorphine, and Other Drugs Market, By Route Of Administration, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Transdermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
7. Morphine, Buprenorphine, and Other Drugs Market, By Distribution Channel, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
8. Morphine, Buprenorphine, and Other Drugs Market, By Region, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
- Purdue Pharma
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Sun Pharmaceuticals
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- West Ward Pharmaceuticals
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Teva Pharmaceuticals
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Piramal Pharmaceuticals
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Hikama Pharmaceuticals
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Indivior PLC
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Oreoxo AB
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Camurus AB
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Novartis
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Purdue Pharma
- Analyst Views
10. Section
- References
- Research Methodology
- About Us
